Editorial: Genetic and Cellular Heterogeneity in Tumors

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2024 Dec 24

PMID 39717843

Authors

Zishan Wang

Li Ma

Juan Xu

Chunjie Jiang

Affiliations

Soon will be listed here.

References

Yip H, Papa A . Signaling Pathways in Cancer: Therapeutic Targets, Combinatorial Treatments, and New Developments. Cells. 2021; 10(3). PMC: 8002322. DOI: 10.3390/cells10030659. View

Esposito M, Ganesan S, Kang Y . Emerging strategies for treating metastasis. Nat Cancer. 2021; 2(3):258-270. PMC: 8064405. DOI: 10.1038/s43018-021-00181-0. View

Chen L, Zhu C, Pan F, Chen Y, Xiong L, Li Y . Platelets in the tumor microenvironment and their biological effects on cancer hallmarks. Front Oncol. 2023; 13:1121401. PMC: 10022734. DOI: 10.3389/fonc.2023.1121401. View

De Kouchkovsky I, Abdul-Hay M . 'Acute myeloid leukemia: a comprehensive review and 2016 update'. Blood Cancer J. 2016; 6(7):e441. PMC: 5030376. DOI: 10.1038/bcj.2016.50. View

Dongre A, Weinberg R . New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2018; 20(2):69-84. DOI: 10.1038/s41580-018-0080-4. View

Ellis M, Gillette M, Carr S, Paulovich A, Smith R, Rodland K . Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium. Cancer Discov. 2013; 3(10):1108-12. PMC: 3800055. DOI: 10.1158/2159-8290.CD-13-0219. View

Kumar P, Aggarwal R . An overview of triple-negative breast cancer. Arch Gynecol Obstet. 2015; 293(2):247-69. DOI: 10.1007/s00404-015-3859-y. View

Katsuta E, Maawy A, Yan L, Takabe K . High expression of bone morphogenetic protein (BMP) 6 and BMP7 are associated with higher immune cell infiltration and better survival in estrogen receptor‑positive breast cancer. Oncol Rep. 2019; 42(4):1413-1421. PMC: 6718975. DOI: 10.3892/or.2019.7275. View

Dai C, Chen M, Wang C, Hao X . Deconvolution of Bulk Gene Expression Profiles with Single-Cell Transcriptomics to Develop a Cell Type Composition-Based Prognostic Model for Acute Myeloid Leukemia. Front Cell Dev Biol. 2021; 9:762260. PMC: 8633313. DOI: 10.3389/fcell.2021.762260. View

10.

Basho R, Chase M . Genetic Testing in Metastatic Breast Cancer in the USA: A Podcast. Oncol Ther. 2023; 11(4):433-443. PMC: 10673788. DOI: 10.1007/s40487-023-00243-6. View

11.

Scully O, Bay B, Yip G, Yu Y . Breast cancer metastasis. Cancer Genomics Proteomics. 2012; 9(5):311-20. View

12.

Docking T, Parker J, Jadersten M, Duns G, Chang L, Jiang J . A clinical transcriptome approach to patient stratification and therapy selection in acute myeloid leukemia. Nat Commun. 2021; 12(1):2474. PMC: 8087683. DOI: 10.1038/s41467-021-22625-y. View

13.

Zhai X, Jiang X . Properties of Leukemic Stem Cells in Regulating Drug Resistance in Acute and Chronic Myeloid Leukemias. Biomedicines. 2022; 10(8). PMC: 9405586. DOI: 10.3390/biomedicines10081841. View

14.

Ostroverkhova D, Przytycka T, Panchenko A . Cancer driver mutations: predictions and reality. Trends Mol Med. 2023; 29(7):554-566. DOI: 10.1016/j.molmed.2023.03.007. View

15.

Ng S, Mitchell A, Kennedy J, Chen W, McLeod J, Ibrahimova N . A 17-gene stemness score for rapid determination of risk in acute leukaemia. Nature. 2016; 540(7633):433-437. DOI: 10.1038/nature20598. View

16.

Vetrie D, Helgason G, Copland M . The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML. Nat Rev Cancer. 2020; 20(3):158-173. DOI: 10.1038/s41568-019-0230-9. View

17.

Li L, Li M, Jia Q . Myeloid-derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in cancer. Pathol Res Pract. 2023; 248:154711. DOI: 10.1016/j.prp.2023.154711. View

18.

Vinay D, Ryan E, Pawelec G, Talib W, Stagg J, Elkord E . Immune evasion in cancer: Mechanistic basis and therapeutic strategies. Semin Cancer Biol. 2015; 35 Suppl:S185-S198. DOI: 10.1016/j.semcancer.2015.03.004. View

19.

Li J, Tsang J, Tse G . Tumor Microenvironment in Breast Cancer-Updates on Therapeutic Implications and Pathologic Assessment. Cancers (Basel). 2021; 13(16). PMC: 8394502. DOI: 10.3390/cancers13164233. View

20.

Newman A, Liu C, Green M, Gentles A, Feng W, Xu Y . Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015; 12(5):453-7. PMC: 4739640. DOI: 10.1038/nmeth.3337. View